SAINT

Dataset

DOI

SAINT was clinical Trial that aimed at evaluating the efficacy of a single dose of ivermectin in reducing the transmission of SARS-CoV-2 when administered early after disease onset (72h).The clinical trial found a tendency to lower viral loads, lower IgG titers, a marked reduction of anosmia/hyposmia, and a reduction of cough in the ivermectin treated group.Rainwater foundation funded an ancillary study to evaluate whether ivermectin can immunomodulate COVID-19 response.

R, nan

Identifier
DOI	https://doi.org/10.34810/data2167
Metadata Access	https://dataverse.csuc.cat/oai?verb=GetRecord&metadataPrefix=oai_datacite&identifier=doi:10.34810/data2167

Provenance
Creator	Marta Ribes ; Cèlia Torres (ORCID: nan); Mar Canyelles ; Rocío Rubio ; Marta Vidal ; Luis Izquierdo ; Andrés Blanco-Di Matteo ; Iñigo Pineda ; Alejandro Fernandez-Montero ; Carlota Jordan-Iborra (ORCID: nan); Francisco Carmona-Torre ; José R Yuste ; Jose L Del Pozo ; Gabriel Reina ; Belen Sadaba (ORCID: nan); Mirian Fernández-Alonso (ORCID: nan); Pere Santamaria ; Carlo Carolis ; Ruth Aguilar ; Dídac Macià ; Carlos Chaccour (ORCID: 0000-0001-9812-050X); Carlota Dobaño ; Gemma Moncunill
Publisher	CORA.Repositori de Dades de Recerca
Contributor	UBIOESGD
Publication Year	2025
Rights	CC BY-NC-SA 4.0; info:eu-repo/semantics/openAccess; http://creativecommons.org/licenses/by-nc-sa/4.0
OpenAccess	true
Contact	UBIOESGD (Barcelona Institute for Global Health)

Representation
Resource Type	Clinical data; Dataset
Format	text/tab-separated-values; text/x-r-notebook; text/plain; application/vnd.openxmlformats-officedocument.spreadsheetml.sheet
Size	2020979; 597106; 5188; 97821; 3288; 6669; 779789; 288913; 226684; 66287
Version	1.0
Discipline	Life Sciences; Medicine